Lung Transplantation for Cystic Fibrosis

Christian A. Merlo

doi:10.1016/B978-0-08-102723-3.00263-8

Lung Transplantation for Cystic Fibrosis

Christian A. Merlo

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The median predicted survival for people with cystic fibrosis (CF) is now over 45years of age, but despite tremendous advances in the management of CF, progressive respiratory failure remains the primary source of morbidity and mortality. CF is the third most common indication for lung transplantation in adults, after chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), and the most common indication in the pediatric population. CF adults have the longest median survival of any group receiving lung transplants.

Original language	English (US)
Title of host publication	Encyclopedia of Respiratory Medicine, Second Edition
Publisher	Elsevier
Pages	643-649
Number of pages	7
Volume	5
ISBN (Electronic)	9780081027240
ISBN (Print)	9780081027233
DOIs	https://doi.org/10.1016/B978-0-08-102723-3.00263-8
State	Published - Jan 1 2021

Keywords

Chronic obstructive pulmonary disease
Cystic fibrosis related diabetes
Extracorporeal life support
Idiopathic pulmonary fibrosis
Lung allocation score

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-08-102723-3.00263-8

Cite this

@inbook{1271c972646b4855b291da4be90ebcc1,

title = "Lung Transplantation for Cystic Fibrosis",

abstract = "The median predicted survival for people with cystic fibrosis (CF) is now over 45years of age, but despite tremendous advances in the management of CF, progressive respiratory failure remains the primary source of morbidity and mortality. CF is the third most common indication for lung transplantation in adults, after chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), and the most common indication in the pediatric population. CF adults have the longest median survival of any group receiving lung transplants.",

keywords = "Chronic obstructive pulmonary disease, Cystic fibrosis related diabetes, Extracorporeal life support, Idiopathic pulmonary fibrosis, Lung allocation score",

author = "Merlo, {Christian A.}",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-08-102723-3.00263-8",

language = "English (US)",

isbn = "9780081027233",

volume = "5",

pages = "643--649",

booktitle = "Encyclopedia of Respiratory Medicine, Second Edition",

publisher = "Elsevier",

}

TY - CHAP

T1 - Lung Transplantation for Cystic Fibrosis

AU - Merlo, Christian A.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - The median predicted survival for people with cystic fibrosis (CF) is now over 45years of age, but despite tremendous advances in the management of CF, progressive respiratory failure remains the primary source of morbidity and mortality. CF is the third most common indication for lung transplantation in adults, after chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), and the most common indication in the pediatric population. CF adults have the longest median survival of any group receiving lung transplants.

AB - The median predicted survival for people with cystic fibrosis (CF) is now over 45years of age, but despite tremendous advances in the management of CF, progressive respiratory failure remains the primary source of morbidity and mortality. CF is the third most common indication for lung transplantation in adults, after chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), and the most common indication in the pediatric population. CF adults have the longest median survival of any group receiving lung transplants.

KW - Chronic obstructive pulmonary disease

KW - Cystic fibrosis related diabetes

KW - Extracorporeal life support

KW - Idiopathic pulmonary fibrosis

KW - Lung allocation score

UR - http://www.scopus.com/inward/record.url?scp=85143093173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143093173&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-102723-3.00263-8

DO - 10.1016/B978-0-08-102723-3.00263-8

M3 - Chapter

AN - SCOPUS:85143093173

SN - 9780081027233

VL - 5

SP - 643

EP - 649

BT - Encyclopedia of Respiratory Medicine, Second Edition

PB - Elsevier

ER -

Lung Transplantation for Cystic Fibrosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this